-+ 0.00%
-+ 0.00%
-+ 0.00%

Dianthus Therapeutics SVP, General Counsel Adam Veness disposes of USD 2.42 million in common shares

PUBT·06/18/2026 20:31:07
Listen to the news
Dianthus Therapeutics SVP, General Counsel Adam Veness disposes of USD 2.42 million in common shares
  • Dianthus Therapeutics SVP, General Counsel and Secretary Adam M. Veness exercised stock options for 30,000 common shares at USD 17.88 on June 17, 2026.
  • He sold 30,000 common shares the same day at weighted-average prices of USD 80.34 and USD 81.38.
  • He reported zero common shares owned following the transactions.
  • He reported 80,000 stock options beneficially owned following the transactions, with an expiration date of Jan. 23, 2034.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001778623-26-000005), on June 18, 2026, and is solely responsible for the information contained therein.